health

Framingham Risk Calculator

Q: Why do men and women have different Framingham equations?

Coronary disease onset and progression differ by sex due to hormonal, genetic, and physiologic variations. Women typically remain protected by estrogen until menopause, delaying disease manifestation by 7–10 years relative to men. Consequently, a woman aged 55 with identical cholesterol, blood pressure, and smoking status as a 55-year-old man faces lower short-term risk, but her cumulative lifetime risk may converge by age 70–75. The separate algorithms capture these sex-specific hazard rates empirically derived from the Framingham cohort.

Q: How accurate is the Framingham Risk Score?

The algorithm demonstrates good discrimination (distinguishing higher-risk from lower-risk individuals) across diverse populations, with c-statistics around 0.72–0.76. However, it systematically overestimates risk in some modern cohorts, partly because treatment for hypertension and hypercholesterolemia has improved since the 1970s–1990s. Used as a screening and counseling tool rather than a definitive prediction, it remains reliable for identifying candidates for preventive therapy. Always integrate it with clinical assessment and patient preferences.

Q: Should I take aspirin based on my Framingham score alone?

No. Aspirin for primary prevention (preventing a first heart attack in asymptomatic individuals) is now recommended selectively. Current guidelines suggest considering low-dose aspirin (75–100 mg/day) only in high-risk patients aged 40–70 and after discussion of benefits and bleeding risks. The Framingham score helps risk stratify, but age, bleeding history, and other factors influence the aspirin decision. Consult your physician before starting or stopping aspirin.

Q: What if I quit smoking—does my risk score improve?

Yes. The calculator captures current smoking status; if you stop, you would recalculate with smoking=0. Most studies show a 50–75% risk reduction within 1–2 years of cessation. After 10–15 years of abstinence, coronary risk approaches that of never-smokers. Recompute your score annually as you maintain cessation, and discuss with your doctor how your changing risk may affect treatment decisions.

Q: Can I use the Framingham score if I have diabetes?

The original Framingham algorithm does not explicitly include diabetes, which is a major limitation. Diabetic patients are now considered high-risk by major guidelines (equivalent to a history of prior myocardial infarction) and warrant intensive preventive therapy regardless of Framingham score. If you have diabetes, consult your physician directly rather than relying solely on this calculator.

Q: How often should I recalculate my Framingham score?

Recalculate annually or after significant changes in blood pressure, cholesterol, or smoking status. As you age, your score will rise due to advancing age alone, even if other factors remain stable. Regular reassessment helps track the impact of lifestyle changes (weight loss, exercise, smoking cessation) and informs decisions about starting or adjusting medications.

The Framingham Risk Score quantifies your likelihood of experiencing a heart attack or coronary death within the next decade using clinical data from a landmark longitudinal study. Clinicians and patients aged 30–79 without prior cardiovascular events rely on this tool to identify risk stratification, guide preventive interventions, and inform shared decision-making about statins and blood pressure control.

Last updated: April 22, 2026

Creators Łucja Zaborowska, MD, PhD

Reviewers Małgorzata Koperska and Adena Benn

6,328 people find this calculator helpful

The Framingham Heart Study: Origins and Impact

In 1948, researchers enrolled 5,209 residents from Framingham, Massachusetts—a small town outside Boston—in what would become the longest-running prospective cardiovascular epidemiology study. None of the initial participants had experienced a heart attack, stroke, or other major cardiovascular events. Over seven decades, investigators meticulously documented every cardiac outcome, correlating disease occurrence with laboratory values, lifestyle factors, and medication use.

This unprecedented dataset revealed which risk factors—age, cholesterol, blood pressure, smoking, and sex—most strongly predicted coronary events. The resulting algorithm has been validated across multiple cohorts and remains a cornerstone of preventive cardiology guidelines worldwide.

Original cohort: 5,209 disease-free adults from a single town
Follow-up duration: Over 70 years of continuous monitoring
Key insight: Combination of modifiable and non-modifiable factors drives risk

Understanding Your Risk Factors

The Framingham calculator integrates six core variables to estimate 10-year coronary risk:

Age: Risk rises progressively; a 45-year-old and 65-year-old with identical other factors face very different probabilities.
Sex: Men develop coronary disease earlier and more frequently than women of the same age until women reach menopause.
Total cholesterol: Elevated levels, particularly LDL particles, accelerate atherosclerotic plaque formation.
HDL cholesterol: The "protective" fraction; higher values reduce risk independent of total cholesterol.
Systolic blood pressure: Chronic elevation damages arterial walls and increases myocardial oxygen demand.
Smoking: Active tobacco use sharply elevates risk through multiple mechanisms: endothelial injury, thrombosis promotion, and arterial stiffening.
Antihypertensive treatment: Use of blood pressure–lowering medications is captured separately to account for treated versus untreated hypertension.

Framingham Risk Score Calculation

The algorithm employs separate equations for men and women, reflecting sex differences in coronary pathophysiology. Logarithmic terms account for non-linear relationships between risk factors and outcome. The final probability is derived by applying the individual risk score to population baseline survival estimates.

Men Risk Score = (52.01 × ln(age)) + (20.01 × ln(total cholesterol))

+ (−0.91 × ln(HDL)) + (1.31 × ln(systolic BP))

+ (0.24 × BP treatment) + (12.1 × smoking)

+ (−4.61 × ln(age) × ln(total cholesterol))

+ (−2.84 × age × smoking) + (−2.93 × ln(age)²) − 172.30

Women Risk Score = (31.76 × ln(age)) + (22.47 × ln(total cholesterol))

+ (−1.19 × ln(HDL)) + (2.55 × ln(systolic BP))

+ (0.42 × BP treatment) + (13.08 × smoking)

+ (−5.06 × ln(age) × ln(total cholesterol))

+ (−3 × age × smoking) − 146.59

10-Year Probability (Men) = 1 − (0.9402^(e^Risk Score))

10-Year Probability (Women) = 1 − (0.98767^(e^Risk Score))

age — Patient age in years (30–79)
total cholesterol — Serum total cholesterol in mg/dL
HDL — High-density lipoprotein cholesterol in mg/dL
systolic BP — Systolic blood pressure in mmHg (top number)
BP treatment — Binary: 1 if taking antihypertensive medication, 0 if not
smoking — Binary: 1 if current smoker, 0 if former or never smoker
ln() — Natural logarithm function
e — Mathematical constant (approximately 2.718)

Critical Considerations and Limitations

The Framingham score is a robust epidemiologic tool, but several practical caveats matter in clinical application.

Not for established disease — This calculator is invalid for anyone with prior myocardial infarction, angina, coronary revascularization, peripheral arterial disease, or stroke. High-risk patients require direct physician evaluation and risk-reducing therapy regardless of score.
Missing risk factors — The algorithm does not incorporate family history, diabetes status, chronic kidney disease, inflammatory markers (hsCRP), or lipoprotein(a)—all of which modify coronary risk. A low Framingham score does not exclude high-risk features.
Systolic BP matters more than diastolic — The equation uses systolic pressure, which better predicts cardiovascular events in older adults. Always record pressure after 5 minutes of rest, and use the average of multiple readings for accuracy.
Smoking status changes risk markedly — Former smokers benefit from a 50–75% risk reduction compared to current smokers within 1–2 years of quitting. Updating smoking status annually can show meaningful shifts in long-term risk.

Interpreting Your Results and Next Steps

The Framingham calculator outputs a percentage: your estimated probability of a coronary event (heart attack or coronary death) in the next 10 years.

Low risk (<10%): Focus on lifestyle: aerobic exercise, heart-healthy diet, weight management, blood pressure <120/80 mmHg, and smoking cessation if applicable.
Intermediate risk (10–20%): Discuss with a clinician whether statins (e.g., atorvastatin 10–20 mg/day) or additional blood pressure control may reduce events. Consider aspirin only if directed by a physician.
High risk (>20%): Intensive pharmacotherapy is warranted. Most patients benefit from a statin, blood pressure medication (target <130/80), and aggressive lifestyle modification.

Remember: this score informs but does not replace clinical judgment. Physicians weigh additional factors—diabetes, family history, kidney function, inflammatory markers—when making treatment decisions. Schedule a follow-up appointment to discuss your results and develop a personalized prevention plan.

Frequently Asked Questions

Why do men and women have different Framingham equations?

Coronary disease onset and progression differ by sex due to hormonal, genetic, and physiologic variations. Women typically remain protected by estrogen until menopause, delaying disease manifestation by 7–10 years relative to men. Consequently, a woman aged 55 with identical cholesterol, blood pressure, and smoking status as a 55-year-old man faces lower short-term risk, but her cumulative lifetime risk may converge by age 70–75. The separate algorithms capture these sex-specific hazard rates empirically derived from the Framingham cohort.

How accurate is the Framingham Risk Score?

The algorithm demonstrates good discrimination (distinguishing higher-risk from lower-risk individuals) across diverse populations, with c-statistics around 0.72–0.76. However, it systematically overestimates risk in some modern cohorts, partly because treatment for hypertension and hypercholesterolemia has improved since the 1970s–1990s. Used as a screening and counseling tool rather than a definitive prediction, it remains reliable for identifying candidates for preventive therapy. Always integrate it with clinical assessment and patient preferences.

Should I take aspirin based on my Framingham score alone?

No. Aspirin for primary prevention (preventing a first heart attack in asymptomatic individuals) is now recommended selectively. Current guidelines suggest considering low-dose aspirin (75–100 mg/day) only in high-risk patients aged 40–70 and after discussion of benefits and bleeding risks. The Framingham score helps risk stratify, but age, bleeding history, and other factors influence the aspirin decision. Consult your physician before starting or stopping aspirin.

What if I quit smoking—does my risk score improve?

Yes. The calculator captures current smoking status; if you stop, you would recalculate with smoking=0. Most studies show a 50–75% risk reduction within 1–2 years of cessation. After 10–15 years of abstinence, coronary risk approaches that of never-smokers. Recompute your score annually as you maintain cessation, and discuss with your doctor how your changing risk may affect treatment decisions.

Can I use the Framingham score if I have diabetes?

The original Framingham algorithm does not explicitly include diabetes, which is a major limitation. Diabetic patients are now considered high-risk by major guidelines (equivalent to a history of prior myocardial infarction) and warrant intensive preventive therapy regardless of Framingham score. If you have diabetes, consult your physician directly rather than relying solely on this calculator.

How often should I recalculate my Framingham score?